- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AMGN
Recent news which mentions AMGN
From MarketWatch
Why Horizon Therapeutics Stock Is Soaring Today
December 12, 2022
From Motley Fool
What's Going On With Amgen Stock Today?
December 12, 2022
From Benzinga
Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal
December 12, 2022
From InvestorPlace
These 2 Nasdaq Stocks Are Soaring on Merger News
December 12, 2022
From Motley Fool
From Benzinga
Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share
December 12, 2022
From Benzinga
Retail capitulation may be a new year’s gift for the stock market, says this analyst
December 12, 2022
From MarketWatch
Amgen reportedly in talks to buy Horizon Therapeutics
December 12, 2022
From MarketWatch
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
December 11, 2022
From Motley Fool
This Monster Dividend Stock Isn't Done Growing
December 08, 2022
From Motley Fool
Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration
December 08, 2022
From Benzinga
Mirati Experimental Lung Cancer Drug Shows Favorable Tolerability, Promising Efficacy
December 06, 2022
From Benzinga
Is AbbVie Stock a Buy Now?
December 06, 2022
From Motley Fool
7 Christmas Stocks to Buy for Happy Holidays
December 05, 2022
From InvestorPlace
FTX Collapse: Lessons for Investors
December 03, 2022
From Motley Fool
From Benzinga
Is Amgen Stock a Buy for Income Investors?
December 02, 2022
From Motley Fool
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
From Benzinga
The S&P 500 is on the cusp of breaking through a level that might spell the end of the bear market
December 01, 2022
From MarketWatch
From Benzinga
Why Horizon Therapeutics Stock Is Skyrocketing Today
November 30, 2022
From Motley Fool
Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?
November 30, 2022
From InvestorPlace
From Benzinga
Horizon Therapeutics Shares Jump On Confirmation Of Takeover Talks With Several Large Companies
November 30, 2022
From Benzinga
Banks are short more than $1 trillion in capital, this analyst says, who fears the shortfall will only get worse
November 30, 2022
From MarketWatch
VALQ Offers Quality-Focused Value Approach
November 22, 2022
From ETF Trends
10 Health Care Stocks Whale Activity In Today's Session
November 22, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.